Indomethacin causes renal epithelial cell injury involving Mcl-1 down-regulation
- 13 March 2009
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 380 (3), 531-536
- https://doi.org/10.1016/j.bbrc.2009.01.094
Abstract
No abstract availableKeywords
Funding Information
- Taichung Veterans General Hospital (TCVGH-945004B)
This publication has 26 references indexed in Scilit:
- Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKTEuropean Journal of Pharmacology, 2007
- Association of Selective and Conventional Nonsteroidal Antiinflammatory Drugs with Acute Renal Failure: A Population-based, Nested Case-Control AnalysisAmerican Journal of Epidemiology, 2006
- Cyclooxygenase-2 Inhibition Induces Apoptosis Signaling via Death Receptors and Mitochondria in Hepatocellular CarcinomaCancer Research, 2006
- Antiproliferative effect of indomethacin on CML cells is related to the suppression of STATs/Bcl-XL signal pathwayAnnals of Hematology, 2006
- BCL-2: found bound and drugged!Trends in Molecular Medicine, 2005
- Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocationHepatology, 2004
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI Journal of the National Cancer Institute, 2002
- The biochemistry of apoptosisNature, 2000
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984